NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

15 hedge funds and large institutions have $2.25M invested in Northwest Biotherapeutics, Inc. Common stock in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$484K
2
+$22.8K
3
+$15.7K
4
AMG
Advisors Management Group
Wisconsin
+$8K
5
WJWM
Williams Jones Wealth Management
New York
+$3.92K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.45M
2
$413K
3
$224K
4
$47K
5
$34.5K
6
$16K
7
$15.7K
8
$11.5K
9
$11K
10
$10K
11
$8K
12
$5.49K
13
$3.37K
14
$3K